{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:09:25Z","timestamp":1778843365959,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["MUMS 4001146"],"award-info":[{"award-number":["MUMS 4001146"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4001146"],"award-info":[{"award-number":["4001146"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.msard.2024.105659","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T11:55:36Z","timestamp":1714391736000},"page":"105659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM\/TSP) treatment"],"prefix":"10.1016","volume":"87","author":[{"given":"Afsane","family":"Fadaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Sadat","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazila","family":"Ariaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Ahmadi Ghezeldasht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Kheradmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Boostani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-5992","authenticated-orcid":false,"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105659_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejim.2018.01.019","article-title":"Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly","volume":"49","author":"Abuhasira","year":"2018","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10408363.2022.2157791","article-title":"Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia\/lymphoma (ATLL)","volume":"60","author":"Ahmadi Ghezeldasht","year":"2023","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"7","key":"10.1016\/j.msard.2024.105659_bib0003","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1523\/JNEUROSCI.23-07-02511.2003","article-title":"Therapeutic action of cannabinoids in a murine model of multiple sclerosis","volume":"23","author":"Arevalo-Martin","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0004","first-page":"393","article-title":"HTLV-1 proviral load absolute RT-qPCR development for assessing on clinical outcomes in HAM\/TSP patients","volume":"12","author":"Ariaee","year":"2023","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.msard.2024.105659_bib0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jcp.53.8.581","article-title":"HTLV-1 infections","volume":"53","author":"Bangham","year":"2000","journal-title":"J. Clin. Pathol."},{"issue":"19","key":"10.1016\/j.msard.2024.105659_bib0006","first-page":"2299","article-title":"HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma","volume":"141","author":"Bangham","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.msard.2024.105659_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005285","article-title":"Cytoplasmic localization of HTLV-1 HBZ protein: a biomarker of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"11","author":"Baratella","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.msard.2024.105659_bib0008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-011-8210-5","article-title":"Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease","volume":"51","author":"Basu","year":"2011","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.msard.2024.105659_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.msard.2024.105659_bib0010","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"8","key":"10.1016\/j.msard.2024.105659_bib0011","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI200317652","article-title":"Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212","volume":"111","author":"Croxford","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.msard.2024.105659_bib0012","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.msard.2024.105659_bib0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14728222.12.2.185","article-title":"Therapeutic potential of CB2 targeting in multiple sclerosis","volume":"12","author":"Docagne","year":"2008","journal-title":"Expert. Opin. Ther. Targets"},{"key":"10.1016\/j.msard.2024.105659_bib0014","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3389\/fmicb.2017.02563","article-title":"Role of HTLV-1 tax and HBZ in the pathogenesis of HAM\/TSP","volume":"8","author":"Enose-Akahata","year":"2017","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.msard.2024.105659_bib0015","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3324\/haematol.2020.272468","article-title":"Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia","volume":"106","author":"Forlani","year":"2021","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.msard.2024.105659_bib0016","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41583-018-0070-8","article-title":"CNS infection and immune privilege","volume":"19","author":"Forrester","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.msard.2024.105659_bib0017","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.msard.2024.105659_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/187152808785107642","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) inflammatory network","volume":"7","author":"Goncalves","year":"2008","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"9","key":"10.1016\/j.msard.2024.105659_bib0019","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.drudis.2019.05.023","article-title":"Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?","volume":"24","author":"Gon\u00e7alves","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"20","key":"10.1016\/j.msard.2024.105659_bib0020","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3390\/ijms21207693","article-title":"Cannabinoid receptors: an update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases","volume":"21","author":"Haspula","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.msard.2024.105659_bib0021","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.3390\/v7112904","article-title":"Human T-lymphotropic virus type I (HTLV-1) infection among iranian blood donors: first case-control study on the risk factors","volume":"7","author":"Hedayati-Moghaddam","year":"2015","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.msard.2024.105659_bib0022","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.3390\/ijms22115431","article-title":"Neuroprotective and immunomodulatory action of the endocannabinoid system under neuroinflammation","volume":"22","author":"Kasatkina","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2024.105659_bib0023","first-page":"294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Front. Cell Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2024.105659_bib0024","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2024.105659_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-5728(97)00226-9","article-title":"Marijuana, immunity and infection","volume":"83","author":"Klein","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0026","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ejp.1147","article-title":"Availability and approval of cannabis-based medicines for chronic pain management and palliative\/supportive care in Europe: a survey of the status in the chapters of the European Pain Federation","volume":"22","author":"Krcevski-Skvarc","year":"2018","journal-title":"Eur. J. Pain"},{"issue":"1","key":"10.1016\/j.msard.2024.105659_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1212\/WNL.45.1.30","article-title":"Assessment of MRI criteria for MS in Japanese MS and HAM\/TSP","volume":"45","author":"Kuroda","year":"1995","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2024.105659_bib0028","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm0502-509","article-title":"Autoimmunity due to molecular mimicry as a cause of neurological disease","volume":"8","author":"Levin","year":"2002","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.msard.2024.105659_bib0029","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2024.105659_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1742-4690-6-71","article-title":"The HBZ gene, a key player in HTLV-1 pathogenesis","volume":"6","author":"Matsuoka","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.msard.2024.105659_bib0031","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fncel.2020.00034","article-title":"Perspectives on cannabis-based therapy of multiple sclerosis: a mini-review","volume":"14","author":"Mecha","year":"2020","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.msard.2024.105659_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12977-015-0221-1","article-title":"HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection","volume":"12","author":"Melamed","year":"2015","journal-title":"Retrovirology"},{"issue":"7","key":"10.1016\/j.msard.2024.105659_bib0033","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830250723","article-title":"A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells","volume":"25","author":"Mendel","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2024.105659_bib0034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12977-019-0508-8","article-title":"An insight to HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis","volume":"16","author":"Mozhgani","year":"2019","journal-title":"Retrovirology"},{"issue":"7","key":"10.1016\/j.msard.2024.105659_bib0035","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med. Chem."},{"issue":"7","key":"10.1016\/j.msard.2024.105659_bib0036","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1007\/s12035-017-0792-z","article-title":"Photobiomodulation therapy improves acute inflammatory response in mice: the role of cannabinoid receptors\/ATP-Sensitive K(+) channel\/p38-MAPK signalling pathway","volume":"55","author":"Neves","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.msard.2024.105659_bib0037","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/1352458504ms1009oa","article-title":"Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte\/endothelial interactions in an experimental autoimmune encephalomyelitis model","volume":"10","author":"Ni","year":"2004","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2024.105659_bib0038","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s13365-020-00881-w","article-title":"Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"26","author":"Nozuma","year":"2020","journal-title":"J. Neurovirol."},{"issue":"11","key":"10.1016\/j.msard.2024.105659_bib0039","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","article-title":"Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study","volume":"63","author":"Olindo","year":"2006","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105659_bib0040","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.3390\/ijms23063344","article-title":"Cannabinoids: therapeutic use in clinical practice","volume":"23","author":"Pagano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.msard.2024.105659_bib0041","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1074\/jbc.M707960200","article-title":"The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis","volume":"283","author":"Palazuelos","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0042","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/01.wnl.0000251300.24540.c4","article-title":"Differentiation of HAM\/TSP from patients with multiple sclerosis infected with HTLV-I","volume":"68","author":"Puccioni-Sohler","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0043","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","article-title":"High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey","volume":"52","author":"Rafatpanah","year":"2011","journal-title":"J. Clin. Virol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2024.105659_bib0044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2012.05.004","article-title":"The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran","volume":"250","author":"Rafatpanah","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7224\/1537-2073.2022-006","article-title":"Multiple sclerosis and use of medical cannabis: a retrospective review of a neurology outpatient population","volume":"25","author":"Rainka","year":"2023","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2024.105659_bib0046","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00430-018-0568-8","article-title":"Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients","volume":"208","author":"Rajaei","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.msard.2024.105659_bib0047","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12977-015-0186-0","article-title":"Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL","volume":"12","author":"Raval","year":"2015","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.msard.2024.105659_bib0048","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S1928","article-title":"Cannabinoids in the management of difficult to treat pain","volume":"4","author":"Russo","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.msard.2024.105659_bib0049","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3389\/fmicb.2019.01101","article-title":"Association between HTLV-1 genotypes and risk of HAM\/TSP","volume":"10","author":"Saito","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.msard.2024.105659_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers","volume":"4","author":"Santos","year":"2004","journal-title":"BMC Infect. Dis."},{"issue":"24","key":"10.1016\/j.msard.2024.105659_bib0051","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1021\/acs.jmedchem.7b00155","article-title":"Perspectives of cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative disorders: structure-affinity relationship (SAfiR) and structure-activity relationship (SAR) studies","volume":"60","author":"Spinelli","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.msard.2024.105659_bib0052","article-title":"Cannabinoids as key regulators of inflammasome signaling: a current perspective","volume":"11","author":"Suryavanshi","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.msard.2024.105659_bib0053","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/antiox11102049","article-title":"Intracellular molecular targets and signaling pathways involved in antioxidative and neuroprotective effects of cannabinoids in neurodegenerative conditions","volume":"11","author":"Tadijan","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.msard.2024.105659_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2023.100453","article-title":"HTLV-1-associated demyelinating neuropathy: a case report and review of the literature","volume":"31","author":"Tamaki","year":"2023","journal-title":"eNeurologicalSci."},{"key":"10.1016\/j.msard.2024.105659_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.993025","article-title":"Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1","volume":"13","author":"Tanaka","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2024.105659_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2016.11.009","article-title":"The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis","volume":"228","author":"Tarokhian","year":"2017","journal-title":"Virus Res."},{"issue":"23","key":"10.1016\/j.msard.2024.105659_bib0057","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB(2) receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0058","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/v14030587","article-title":"Clonal selection and evolution of HTLV-1-infected cells driven by genetic and epigenetic alteration","volume":"14","author":"Yamagishi","year":"2022","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.msard.2024.105659_bib0059","doi-asserted-by":"crossref","first-page":"e6517","DOI":"10.1371\/journal.pone.0006517","article-title":"Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder","volume":"4","author":"Yamano","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2024.105659_bib0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.msard.2024.105659_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107669","article-title":"An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) focusing on clinical and laboratory biomarkers","volume":"218","author":"Yamauchi","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.msard.2024.105659_bib0062","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","article-title":"Delta 9-tetrahydrocannabinol regulates Th1\/Th2 cytokine balance in activated human T cells","volume":"133","author":"Yuan","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.msard.2024.105659_bib0063","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2024.105659_bib0064","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:29:20Z","timestamp":1778840960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824002360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":64,"alternative-id":["S2211034824002360"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105659","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM\/TSP) treatment","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105659"}}